
πΆββοΈπ Giant Strides with Weekly Semaglutide Jabs!
Dr RR Baliga's "Got Knowledge Doc" Podkast
April 5, 20253m 4s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
πΆββοΈ The STRIDE trial tested semaglutide in patients with PAD and type 2 diabetes.
π Weekly injections for 52 weeks improved walking distance, pain-free mobility, and quality of life.
π Results showed significant gains vs placebo, with low adverse events.
π Semaglutide may offer a new stride forward in treating functional limitations in PAD.